Loading…
Rapid Micro Biosystems, Inc. is projected to rise to $2.42 by 2027, a +14% move from its current price of $2.13. RPID is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.07 | $2.13 | $2.20 | +0.04% |
| Aug 6 | $2.04 | $2.13 | $2.22 | +0.08% |
| Aug 7 | $2.03 | $2.13 | $2.25 | +0.13% |
| Aug 8 | $2.01 | $2.13 | $2.26 | +0.17% |
| Aug 9 | $2.00 | $2.13 | $2.28 | +0.21% |
| Aug 10 | $1.99 | $2.14 | $2.30 | +0.25% |
| Aug 11 | $1.97 | $2.14 | $2.31 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.97 | $2.14 | $2.31 | +0.29% |
| Week 2 | $1.92 | $2.14 | $2.39 | +0.59% |
| Week 3 | $1.87 | $2.15 | $2.46 | +0.88% |
| Week 4 | $1.84 | $2.16 | $2.52 | +1.18% |
| Week 5 | $1.81 | $2.16 | $2.58 | +1.48% |
| Week 6 | $1.79 | $2.17 | $2.63 | +1.78% |
| Week 7 | $1.77 | $2.17 | $2.68 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rapid Micro Biosystems, Inc. is a life sciences technology company that provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. Its Growth Direct platform includes the Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
The platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables.
The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software.
Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Rapid Micro Biosystems, Inc. (RPID) is the asset. The current price is $2.13 and the market cap is $106.12M, reflecting its small-cap stature and niche focus within healthcare technology.
Its rank is 4119, placing it among smaller public companies by market capitalization. The forecast implies an upside path over the coming years, with a long-run bullish outlook: 2026 avg $2.13, 2030 avg $4.28, 2040 avg $10.40, and 2050 avg $24.25, accompanied by projected ROIs of 101%, 388.1%, and 1038.6% at those horizons respectively.
Overall, the long-term outlook shows significant upside potential, contingent on execution and market conditions, with neutral near-term signals transitioning to bullish sentiment as the forecast horizon extends.
A major floor 30.7% below — a decisive break under it would weaken the trend.
The nearest floor, 21.1% below — buyers have tended to step in here.
The nearest ceiling, 3.8% above — a clean break opens room to run.
A major ceiling 23.5% above — clearing it would confirm fresh momentum.
Key RPID support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RPID market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.07 | Buy | $2.09 | Buy |
| MA 10 | $2.06 | Buy | $2.06 | Buy |
| MA 20 | $2.00 | Buy | $2.01 | Buy |
| MA 50 | $1.91 | Buy | $2.03 | Buy |
| MA 100 | $2.18 | Sell | $2.28 | Sell |
| MA 200 | $2.94 | Sell | $2.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.11 | Neutral |
| Stoch RSI (14) | 49.55 | Neutral |
| CCI (20) | 80.35 | Neutral |
| Williams %R (14) | -36.36 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -3.62 | Sell |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 63.64 | Neutral |
| TRIX (15) | 0.39 | Buy |
| Awesome (5,34) | 0.19 | Buy |
| Ultimate (7,14,28) | 63.91 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 2.11 | Buy |
| ADX (14) | 21.99 | Buy |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is bullish. RSI(14) is 60, indicating positive momentum without being overbought.
The trend is reflected in the moving averages: SMA50 is $1.91 and SMA200 is $2.94, suggesting the price is hovering around a value between short- and long-term averages. Support is at $1.68 and resistance at $2.21, providing a defined bandwidth for near-term moves.
The 30-day range runs from a low of $1.75 to a high of $2.59, indicating a relatively tight trading band around the current price and a modest upside potential if buyers push through the resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.66 | $2.13 | $2.64 | 0% | Neutral | |
| $1.91 | $2.42 | $3.24 | +14% | Neutral | |
| $2.28 | $2.97 | $4.14 | +39% | Bullish | |
| $2.87 | $3.84 | $5.54 | +80% | Bullish | |
| $3.12 | $4.28 | $6.32 | +101% | Bullish | |
| $3.38 | $4.72 | $7.14 | +121% | Bullish | |
| $3.57 | $5.09 | $7.86 | +139% | Bullish | |
| $3.63 | $5.27 | $8.29 | +147% | Bullish | |
| $3.94 | $5.81 | $9.29 | +173% | Bullish | |
| $4.48 | $6.72 | $10.92 | +216% | Bullish | |
| $6.43 | $10.40 | $18.06 | +388% | Bullish | |
| $13.14 | $24.24 | $46.29 | +10.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.66 | $2.13 | $2.53 | +0.00% |
| September 2026 | $1.82 | $2.15 | $2.63 | +1.14% |
| October 2026 | $1.85 | $2.21 | $2.73 | +2.73% |
| November 2026 | $1.79 | $2.16 | $2.69 | -2.60% |
| December 2026 | $1.74 | $2.10 | $2.64 | -2.45% |
Click any year to see its month-by-month RPID forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RPID to range from $1.66 to $2.64 through 2026. The $2.13 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RPID price prediction for 2027 points to an average of $2.42 (low $1.91, high $3.24) — a potential gain of +14% on today's $2.13. A consolidation phase looks the most probable path here.
In 2028, RPID is projected to trade between $2.28 and $4.14, averaging $2.97 — a potential gain of +39% from today's $2.13. That is up +23% on the projected 2027 average. Momentum favours further upside here.
Rapid Micro Biosystems, Inc.'s 2029 outlook centres on $3.84, within a $2.87 to $5.54 range. That is up +29% on the projected 2028 average. That marks a +80% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RPID could reach as high as $6.32, with a base case around $4.28 and support toward $3.12 — roughly +101% from $2.13. Momentum favours further upside here.
Expect RPID to range from $3.38 to $7.14 through 2031. The $4.72 average target implies a +121% move from current prices. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RPID price prediction for 2032 points to an average of $5.09 (low $3.57, high $7.86) — a potential gain of +139% on today's $2.13. Momentum favours further upside here.
In 2033, RPID is projected to trade between $3.63 and $8.29, averaging $5.27 — a potential gain of +147% from today's $2.13. That is up +4% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Rapid Micro Biosystems, Inc.'s 2034 outlook centres on $5.81, within a $3.94 to $9.29 range. That is up +10% on the projected 2033 average. That marks a +173% change versus current levels. Momentum favours further upside here.
By 2035, RPID could reach as high as $10.92, with a base case around $6.72 and support toward $4.48 — roughly +216% from $2.13. Buyers look set to stay in control over this stretch.
Expect RPID to range from $6.43 to $18.06 through 2040. The $10.40 average target implies a +388% move from current prices. That is up +55% on the projected 2035 average. Momentum favours further upside here.
The RPID price prediction for 2050 points to an average of $24.24 (low $13.14, high $46.29) — a potential gain of +10.4x on today's $2.13. Buyers look set to stay in control over this stretch.
Investing $1,000 in RPID today (≈ 469.483568 RPID) could be worth
$11,380.75
+$10,380.75 (+1038%) by 2050 · US Dollar
Based on the average projected RPID price of $24.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RPIDwould be worth at today's price.
$1,000 invested in RPID on Jul 31, 2025 (≈ 300.300307 RPID) would be worth
$639.64
-$360.36 (-36.0%) today · 0.64× · US Dollar
Based on a RPID entry price of $3.33 vs. today's $2.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.99 | $1,070.35 | +7.0% |
| 1 month ago | $1.71 | $1,245.61 | +24.6% |
| 3 months ago | $2.53 | $841.9 | -15.8% |
| 6 months ago | $4.19 | $508.35 | -49.2% |
| 1 year ago | $3.33 | $639.64 | -36.0% |
| All time (5.0y) ago | $24.8 | $85.89 | -91.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RPID forecast.
Our base-case forecast reaches $4.30 around 2031.
Implied market cap at $4.30: $194.89M
The multi-year forecast envisions a rising trajectory for Rapid Micro Biosystems, with 2030 an average price of $4.28 and 2050 an average price of $24.25, yielding ROI figures of 101% and 1038.6% respectively. The forecast also shows mid-term milestones, with 2028 avg $2.97 and 2029 avg $3.85, continuing to higher levels into the 2030s and beyond. Sentiment shifts from neutral in 2026 and 2027 to bullish from 2028 onward, aligning with a sustained growth outlook.
This path implies sustained upside through 2030, 2040, and 2050, with 2040 averaging $10.40 and 388.1% ROI, and 2050 averaging $24.25 with 1038.6% ROI. These figures are estimates and not guarantees, and actual results depend on numerous factors including market conditions and company performance. Year-by-year averages beyond 2026 include 2026 avg $2.13, 2027 avg $2.42, 2028 avg $2.97, 2029 avg $3.85, 2030 avg $4.28, 2031 avg $4.71, 2032 avg $5.09, 2033 avg $5.27, 2034 avg $5.80, 2035 avg $6.73, 2040 avg $10.40, and 2050 avg $24.25.
Tap a question to reveal the answer.
2030 avg $4.28, min $3.13, max $6.33; ROI 101%; sentiment BULLISH.
The forecast shows neutral sentiment in 2026 and 2027, turning bullish from 2028 onward, with long-term ROIs reaching 101% (2030), 388.1% (2040), and 1038.6% (2050), indicating potential upside but these are estimates, not guarantees.
Yes. The 2040 forecast shows an average price of $10.40, with a min of $6.43 and a max of $18.05, and a projected ROI of 388.1%.
Current price is $2.13 and market cap is $106.12M; the rank is 4119.
2050 min $13.15, avg $24.25, max $46.31; ROI 1038.6%; sentiment BULLISH.
Rapid Micro Biosystems, Inc. Community Discussion
0Share your Rapid Micro Biosystems, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.